Prestige Consumer Healthcare Inc. (PBH) is a Medical - Distribution company in the Healthcare sector, currently trading at $56.66. It has a SharesGrow Score of 73/100, indicating a above average investment profile with 6 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of PBH = $101.45 (+79.1% from the current price, the stock appears undervalued). Analyst consensus target is PBH = $66 (+16.5% upside).
Valuation: PBH trades at a trailing Price-to-Earnings (P/E) of 14.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.22.
Financials: revenue is $1.1B, +1.6%/yr average growth. Net income is $215M, growing at +72.3%/yr. Net profit margin is 18.9% (healthy). Gross margin is 55.8% (-1.3 pp trend).
Balance sheet: total debt is $52M against $1.8B equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 4.2 (strong liquidity). Debt-to-assets is 1.5%. Total assets: $3.4B.
Analyst outlook: 12 / 17 analysts rate PBH as buy (71%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 73/100 (Pass), Past 75/100 (Partial), Health 83/100 (Pass), Moat 70/100 (Pass), Future 79/100 (Pass), Income 70/100 (Pass).
